ALVOW - Alvotech


0.25
-0.010   -4.000%

Share volume: 2,165
Last Updated: 05-12-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.21%

PREVIOUS CLOSE
CHG
CHG%

$0.26
-0.01
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
25.00%
1 Month
-13.79%
3 Months
-17.36%
6 Months
-68.12%
1 Year
-85.88%
2 Year
-91.35%
Key data
Stock price
$0.25
P/E Ratio 
0.00
DAY RANGE
$0.23 - $0.25
EPS 
N/A
52 WEEK RANGE
$0.15 - $3.00
52 WEEK CHANGE
-$85.88
MARKET CAP 
2.854 B
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.05
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$7,429
AVERAGE 30 VOLUME 
$5,811
Company detail
CEO: Mark L. PhD
Region: US
Website: alvotech.com
Employees: 4
IPO year: 2022
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

N/A

Recent news